The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.

One dermaplaner compared the mist with face oil in a split-face test—spray on one side, rosehip seed oil on the other—to see which method was more effective, less irritating, and generally more ...

Though they may evoke memories of crunchy hair gel and sweaty pre-teen hands, the best spray deodorants has never been more ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

Milestone announced further details on its in-person and virtual Commercial Launch Plan investor event to take place in New York on Tuesday, ...

There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer of NasoGel Spray, has issued an international recall of 89,312 of its sprays ...

Joe Walsh is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...

China's National Medical Products Administration (NMPA) has approved Keymed Biosciences’ supplemental new drug application ...

As a nurse, I’ve seen how the virus can cause serious health complications. Check out the following items to keep on hand to ...

MDR Certification Strengthens Resyca's Leadership in Soft Mist Drug-Device Combination Products ENSCHEDE, NL / ACCESS Newswire / January 28, 2025 / Resyca BV, a pioneering leader in the development an ...

PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)- Commercial capabilities ...

PDUFA date of March 27, 2025 for CARDAMYST (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT) - Commercial capabilities build out in process, with proposed launch in PSVT targe ...